(LONDON) ONS Breakthrough Cases Report: Where infection occurs in people ‘fully vaccinated’ and deaths involving #COVID19 who also had first positive PCR Test at least 14-days after 2nd vaccine dose #AceHealthDesk report

#AceHealthReport – Sept.18: “ Breakthrough cases” are where infection has occurred in someone who is fully vaccinated. We define a “breakthrough death” as a death involving coronavirus (COVID-19) that occurred in someone who had received both vaccine doses, and had a first positive PCR test at least 14 days after the second vaccination dose. In total, there were 256 breakthrough deaths between 2 January and 2 July 2021 (Table 2)….

#CoronavirusNewsDesk says this is an ONS report from Jan.02 – July.02: 2021: On Cases of people who have received two doses of vaccine and showed 256 breakthrough deaths between those dates above ….

5. Characteristics of breakthrough deaths

We used the Public Health Data Asset (PHDA) to investigate the characteristics of breakthrough cases, leveraging information from the General Practice Extraction Service (GPES) data for coronavirus (COVID-19) pandemic planning and research and Hospital Episode Statistics (HES). The linked data includes 252 breakthrough deaths and 43,956 total deaths involving COVID-19, 98.4% and 85.7% respectively of all breakthrough and total deaths involving COVID-19 that occurred between 2 January and 2 July 2021.

Table 3 shows some characteristics of these deaths.

Notes:
  1. Office for National Statistics (ONS) figures based on death registrations up to 28 July 2021 for deaths that occurred between 2 January and 2 July 2021 (Week 1 – Week 26).
  2. Statistics are calculated using the Public Health Data Asset, a linked dataset of people resident in England who could be linked to the 2011 Census and GP Patient Register.
  3. Deaths were defined using the International Classification of Diseases, tenth revision (ICD-10). Deaths involving the coronavirus (COVID-19) are defined as those with an underlying cause, or any mention of, ICD-10 codes U07.1 (COVID-19 virus identified) or U07.2 (COVID-19, virus not identified). Please note, this differs from the definition used in the majority of mortality outputs (see Glossary).
  4. Age is defined on the date of death.
  5. See Glossary for definitions of health-related variables.

The median age for breakthrough deaths was 84 and 61.1% of the deaths occurred in males, despite there being more elderly women than men, and therefore initially more fully vaccinated women who could experience a breakthrough death. For all other deaths involving COVID-19 occurring between 2 January and 2 July 2021 in the PHDA dataset, the median age was 82 and 52.2% were male.

13.1% of the breakthrough deaths occurred in people who were immunocompromised, compared to 5.4% for other deaths involving COVID-19. Individuals were identified as immunocompromised if they had experienced a hospital episode since 1 January 2019 where the diagnosis or procedure code corresponded to an immunocompromised condition, or who had died and a condition corresponding to being immunocompromised was listed on the death certificate (see Measuring the data).

A greater proportion of breakthrough deaths occurred in those who were clinically extremely vulnerable (76.6%, 193 deaths), than other COVID-19 deaths (74.5%, 32,567 deaths) or non-COVID-19 deaths (69.7%, 128,454 deaths). A similar trend is observed for disability and long-term health problem status, with proportions of deaths among people self-reporting that they are “limited a lot” on the 2011 Census as 31.7%, 27.8% and 24.2% for breakthrough deaths, other deaths involving COVID-19 and non-COVID-19 deaths respectively. However, the characteristics of breakthrough deaths can reflect the characteristics of the population that is more likely to be double vaccinated as well as having an increased risk of a breakthrough death, and numbers are relatively low and should therefore be interpreted with caution.Back to table of contents

6. Glossary

Age standardised mortality rates

Age-standardised mortality rates (ASMRs) are used to allow comparisons between populations that may contain different proportions of people of different ages and sex. The 2013 European Standard Population is used to standardise rates. In this bulletin, the ASMRs are calculated for each week. For more information see Section 7: Measuring the data.

Coronaviruses

The World Health Organization (WHO) defines coronaviruses as “a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS)”. Between 2001 and 2018, there were 12 deaths in England and Wales due to a coronavirus infection, with a further 13 deaths mentioning the virus as a contributory factor on the death certificate.

Coronavirus (COVID-19)

COVID-19 refers to the “coronavirus disease 2019” and is a disease that can affect the lungs and airways. It is caused by a type of coronavirus. Further information is available from the World Health Organization (WHO).

Statistical significance

The term “significant” refers to statistically significant changes or differences. Significance has been determined using the 95% confidence intervals, where instances of non-overlapping confidence intervals between estimates indicate the difference is unlikely to have arisen from random fluctuation.

95% confidence intervals

A confidence interval is a measure of the uncertainty around a specific estimate. If a confidence interval is 95%, it is expected that the interval will contain the true value on 95 occasions if repeated 100 times. As intervals around estimates widen, the level of uncertainty about where the true value lies increases. The size of the interval around the estimate is strongly related to the number of deaths, prevalence of health states and the size of the underlying population. At a national level, the overall level of error will be small compared with the error associated with a local area or a specific age and sex breakdown. More information is available on our uncertainty pages.

Deaths involving COVID-19

For this analysis we define a death as involving COVID-19 if either of the ICD-10 codes U07.1 (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified) is mentioned on the death certificate. In contrast to the definition used in the weekly deaths release, deaths where the ICD-10 code U09.9 (post-COVID condition, where the acute COVID-19 had ended before the condition immediately causing death occurred) is mentioned on the death certificate and neither of the other two COVID-19 codes are mentioned are not included, as they are likely to be the result of an infection caught a long time previously, and therefore not linked to the vaccination status of the person at date of death. Deaths involving U10.9 (multisystem inflammatory syndrome associated with COVID-19) where U07.1 or U07.2 are mentioned are also excluded. This is a rare complication affecting children, and there are no such deaths in our dataset for the data released in Deaths involving COVID-19 by vaccination status, England: deaths occurring between 2 January and 2 July 2021. 

Limitation by a long-term health problem of disability

Limitation by a long-term health problem or disability is self-reported on the 2011 Census for the question, “Are your day-to-day activities limited because of a health problem or disability which has lasted, or is expected to last, at least 12 months?”. Answers are one of, “Yes, limited a lot”, “Yes, limited a little”, or “No”.

Clinical vulnerability

Clinical vulnerability is determined according to the QCOVID risk model for health conditions that result in a higher risk of COVID-19. Health conditions are determined using the General Practice Extraction Service (GPES) and Hospital Episode Statistics (HES) data.

Immunocompromised

A person was identified as immunocompromised if they had a hospital episode recorded in the Hospital Episode Statistics dataset (HES) Admitted Patient Care dataset that started on or after 1 January 2019, with a diagnosis code (ICD-10) or procedure code (OPCD) corresponding to a condition that is associated with either primary or secondary immunosuppression. A person was also flagged as immunocompromised if they died and at least one of these ICD-10 diagnosis codes was mentioned on the death certificate or if they had SNOMED codes recorded in the General Practice Extraction Service dataset corresponding to a prescription of immunosuppressants.

The ICD-10 diagnosis codes included are based on the Immunocompromised State Diagnosis codes from the US Agency for Healthcare Research and Quality. These are ICD-10-CM codes, therefore we used only those codes that were up to 4 digits long to correspond to ICD-10 codes. 

The OPCS-4 procedure codes are based on the OPCS-4 codes listed in the NHS shielding list published by NHS Digital for the following disease groups: transplant, or cancer undergoing active chemo or radiotherapy.

Full lists of the ICD-10 codes and OPCS-4 codes used are given in the reference tables.

Date infected with COVID-19

The first positive test date of the most recent COVID-19 infection recorded in Test and Trace data is used to determine when a person who died from COVID-19 was infected relative to their vaccination data. The absence of a positive test can be either due to a linkage failure (the person was tested but we could not find them in the Test and Trace dataset) or to infection having occurred either not in England or before mass testing was available.

A COVID-19 infection can have multiple positive test results, and a person may be reinfected at a later period. The first positive test result was taken as the start of the first infection, and subsequent infections were determined as starting on the first positive test date that occurred >90 days after the start of the previous infection. The most recent infection is then defined as the start of the last recorded infection.

NOTE: This data is subject to change or fluctuation

#AceHealthDesk report ……..Published: Sept.18: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here:  https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#covid19, #london, #ons, #pcr-test, #vaccine

(LONDON) Press Release MHRA Statement Report: On #COVID19 booster vaccines for Winter 2021 – 2022 #AceHealthDesk report

#AceHealthReport – Sept.15: We are committed to getting safe and effective COVID-19 vaccines to the UK public. This means ensuring that existing COVID-19 vaccines can continue to be used in the most effective way possible…..

#CoronavirusNewsDesk reports on Regulatory updates by the MHRA today on the #COVID19 booster vaccine programme for winter 2021 to 2022…..

Dr June Raine, MHRA Chief Executive said:

We confirmed on 9 September 2021 that the COVID-19 vaccines made by Pfizer and AstraZeneca can be used as safe and effective booster doses. This is an important regulatory change as it gives further options for the vaccination deployment programme which has saved tens of thousands of lives.

The regulatory decision followed a careful review of available data on safety and effectiveness of booster or supplementary vaccine doses by the MHRA and the independent Commission on Human Medicines(CHM, which advises the government.

We have also now looked at data for the Moderna vaccine to be used as a booster, and this has also been reviewed by the CHM experts who concluded that the Moderna vaccine can be used as a safe and effective booster dose, including in a half dose, which also gives an effective boost to antibodies.

The CHM took into account data on waning vaccine effectiveness after the second dose, providing important insights into potentially waning immunity.

The data reviewed showed that giving the booster jabs with flu vaccines at the same time is safe and does not affect an individual’s immune response to either vaccine. Therefore COVID-19 booster doses may be given at the same time as flu vaccines.

We have in place a comprehensive safety surveillance strategy for monitoring the safety of all COVID-19 vaccines and this surveillance includes booster jabs.

As with first and second doses, if anyone has a suspected side effect, please report it to us using our Yellow Card scheme.

#AceHealthDesk report ……Published: Sept.15: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#health, #london, #mhra, #vaccine

(PARIS) #Coronavirus Report: French vaccine maker Valneva says the UK government has scrapped a deal for its #COVID19 vaccine #AceHealthDesk report

#AceHealthReport – Sept.13: The UK had about 100 million doses on order, after it increased its request by 40 million in February…..

#CoronavirusNewsDesk says that UK has scrapped the #COVID19 vaccine deal with French firm Valneva the company said in a statement that the UK government served notice over allegations of a breach of the agreement, which it “strenuously denies” as the Valneva’s jab is still being tested in trials although regulators must be satisfied before the rollout of any vaccine, manufacturing at a site in West Lothian, Scotland, had already started……..

Vials of vaccine against the coronavirus

In a statement on its website, Valneva said: “Valneva SE, a specialty vaccine company, today announced that it has received a termination notice from the UK Government (HMG) in relation to the Supply Agreement for its Covid-19 vaccine candidate, VLA2001: The contract provides HMG with the right to terminate. HMG has alleged that the company is in breach of its obligations under the supply agreement, but the company strenuously denies this.”…….The firm said on Monday that results from its phase three trials were due later this year: It added: “Valneva has worked tirelessly, and to its best efforts, on the collaboration with HMG including investing significant resources and effort to respond to HMG’s requests for variant-derived vaccines.”………The company hopes that, dependent on the results of its continuing trials and sign-off from the UK’s Medicines and Healthcare products Regulatory Agency, initial approval could still be granted in 2021: Its vaccine is expected to be given as two doses and contains a dead version of coronavirus that cannot cause disease, but should teach the body’s immune system how to fight it: But given that it is not yet approved for use by UK regulators, it will not affect the current rollout of jabs.

Speaking to BBC Radio’s Good Morning Scotland, Scotland’s Health Secretary Humza Yousaf said: “We have enough supply even for a booster programme. I want to give absolute confidence to anyone listening that we have the supplies necessary to continue to vaccinate and particularly with a booster programme on the horizon.” …..Mr Yousaf said that while the announcement would be a big set-back for the Livingston plant, he would speak to Valneva to discuss its future.Valneva said on Monday that it would also look to other potential customers to ensure that the vaccines can still be used in the fight against the pandemic.The Scottish Health Secretary added that he was waiting for further information from the UK government over Valneva’s alleged failure to meet the terms of its contract.The Department for Health did not immediately respond to the BBC’s request for comment.

#AceHealthDesk report ……Published: Sept.13: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#paris, #u-k-france, #vaccine, #valneva

(ISRAEL) #Coronavirus Study Report: An Israeli study finds that #COVID19 immunity is significantly improved by a third #Pfizer-BioNTech vaccination #AceHealthDesk report

#AceHealthReport – Sept.11: A research team using data from Maccabi Healthcare Services in Tel Aviv found that the rate of infection dropped 48 to 68 percent within a week to 13 days after the third shot of the Pfizer vaccine. In addition, the study found the infection rate dropped even further—70 to 84 percent—two weeks to 20 days after the additional dose, reports Jason Gale of Fortunemagazine.

#CoronavirusNewsDesk says an Israeli Study Finds Third Shot Provides Significant Boost in Covid-19 Immunity: When it comes to #COVID19 vaccinations, it appears the third time is a charm. A new Israeli study finds that people who get a third dose of the Pfizer-BioNTech vaccine have a significantly lower risk of infection from the coronavirus, including the more dangerous #Delta variant.

Covid Booster
(CDC via Pexels)smithsonianmag.com
September 8, 2021 2:54PM:

Israeli study finds infection rate drops dramatically with third Pfizer-BioNTech vaccination

Released on MedRxiv before submission to a peer-reviewed journal, the Israeli Ministry of Health study concludes there are short-term health benefits to receiving a third shot of the Pfizer-BioNTech vaccine.

“Further studies are needed to determine the duration of protection conferred by the third dose and its effect on severe disease,” conclude the researchers, who include Daniel M. Weinberger, an epidemiologist at the Yale School of Public Health.

So far, more than 2 million of Israel’s 9.3 million residents have received the third dose, reports Dov Lieber of the Wall Street Journal. They include 70 percent of Israelis 60 or older and about half who are more than 50 years old.

“If your goal is to provide someone with high levels of short-term immunity, there’s no question that a good way to do this is … through a booster shot,” David Dowdy, an epidemiologist at Johns Hopkins University, who was not involved in the research, tells Gretchen Vogel of Science magazine.

He cautions that more research is needed to find out how long the boosters last since this study only covers a short period of time.

Health officials in Israel also want to know more about the booster’s longevity. They say they don’t know yet if more than three doses will be needed to protect people, though they are moving ahead with plans to give the booster to as many people as possible as the Delta variant continues to spread.

The World Health Organization (WHO) had wanted wealthier nations to hold off on administering boosters until people in poorer countries had received their first shots. However, Hans KlugeWHO Europe’s regional director, is now saying the additional dose should be given to people who are most at risk.

“A third dose of vaccine is not a luxury booster taking away from someone who is still waiting for a first jab,” he tells Hannah Knowles and Lenny Bernstein of the Washington Post. “But it’s basically a way to keep the people safe, the most vulnerable. But at the same time, we need to share. So we need to do it all.”

#AceHealthDesk report ……Published: Sept.11: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#israel, #vaccine

(LONDON) #Coronavirus GOVUK Report: #COVID19 Anti-Body tests to be offered to the public for the first time to establish a natural protection #AceHealthDesk report

#AceHealthReport – Aug.23: Anyone over 18 will be able to opt in when having a PCR test from Tuesday – of those who test positive, up to 8,000 will be sent two home antibody tests. ….

#CoronavirusNewsDesk reports #COVID19 Antibody tests are to be widely offered to the UK public for the first time in a new programme that aims to find out more about how much natural protection people have after getting #coronavirus.

On Sunday the U.K. reported see below for latest figures after coming out of lockdown recently as U.K. prepares to end furlough and everyone can return to normal life ?

A person using a Covid antibody test
Getty Images

The government scheme will offer tests to thousands of adults each day.

Health Secretary Sajid Javid said it would be quick and easy to take part.

The first of the finger-prick tests would have to be done as soon as possible after the positive result, so the body would not have time to generate a detectable antibody response to the infection. 

The second would be taken 28 days later and measure antibodies generated in response to the infection. 

The UK Health Security Agency is to run the programme and will work alongside NHS test and trace services in England, Scotland, Wales and Northern Ireland to use results to monitor levels of antibodies in positive cases. 

Its chief executive Dr Jenny Harries said the scheme would help the UK gain “vital insight” into the impact of the vaccination programme and immune responses to different variants.

Mr Javid said it would build on the “massive wall of defence” that was the vaccination programme and getting involved would help “strengthen our understanding of Covid-19 as we cautiously return to a more normal life”. 

The Department of Health said as well as helping it improve understanding about antibody protection, the scheme could give information about any groups of people who did not develop an immune response after getting coronavirus.

Scotland’s Health Secretary Humza Yousaf welcomed news of the study, saying: “It is vital that we have the fullest understanding possible of vaccine effectiveness and the immune response of the broader population.

“The rollout of this antibody testing study will help us achieve this and could play an important role in the battle to keep the virus under control.”

Antibody tests have been used previously in the UK during the pandemic but in limited numbers, largely on people involved in studies or surveys.

#AceHealthDesk report ………Published: Aug.23: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts from Twitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#antibody, #london, #vaccine

(PARIS, France.) #Coronavirus Report: Thousands of people have flooded the streets of French cities, protesting against the implementation of a mandatory #COVID19 health pass for the general public, as well as compulsory vaccination for certain categories of people #AceHealthDesk report

#AceHealthReport – Aug.08: Mass protests kicked off in several French cities on Saturday, with thousands condemning government plans to toughen anti-coronavirus restrictions.

Demonstrators gather outside the Council d'Etat and Conseil Constitutionnel during protests against the compulsory Covid-19 vaccination for certain workers and the compulsory use of the health pass called for by the French government in Paris on August 5, 2021. © AFP / STEPHANE DE SAKUTIN

#CoronavirusNewsDesk says that thousands have protested across France on Saturday over Macron’s #COVID19 health pass & mandatory vaccination as a huge march was held in Paris, where participants were accompanied by a massive police presence, live footage from RT’s video agency Ruptly shows.

The protest has taken place without any major incident so far, with police and marchers only engaging in minor pushing along the route. At one point, law enforcement could be seen pepper-spraying protesters who tried to push against the police line.

First tensions during the demonstration against the #PassSanitaire in #Paris.  
The security forces use their gas in the face of demonstrators trying to force a cordon of the mobile gendarmerie.#GiletsJaunes #manifs7aout#manifestation7aout pic.twitter.com/yFVSCshL1x

— Ignorance, the root and stem of all evil (@ivan_8848) August 7, 2021

https://youtu.be/K2ZDB6Kz7zk

Large protests have also been staged in other cities across the country. A massive column of protesters marched through the streets of the southwestern coastal city of La Rochelle to condemn the plans for a health pass.

Des milliers de personnes manifestent à #LaRochelle contre le #PassDeLaHonte (@Bleu_Rochelle#Manifestation7aout #Manifs7aoutpic.twitter.com/bNHQM4y31v

— Anonyme Citoyen (@AnonymeCitoyen) August 7, 2021

Another massive protest was held at the northern French city of Lille, with footage from the scene showing the city center flooded with a sea of disgruntled demonstrators.

Lille !!!! pic.twitter.com/QSryTFvASC

— BotOfficielDeRaoult (@linval59) August 7, 2021

Some 200,000 protesters were expected to hit the streets of French cities, according to local media reports, citing police sources. So far, French law enforcement has not released any official estimates on the scale of the ongoing protests.

The latest round of protests, which have rocked the country for the past few weeks, comes after France’s top court deemed most of the controversial legislation package to be constitutional. The legislation, approved by the court on Thursday, is expected to come into force on Monday.

The court shot down several provisions, but greenlit the most controversial ones, including the implementation of mandatory health passes for the general public, which will be required to visit most public venues. The legislation also implements mandatory coronavirus vaccination for frontline healthcare workers and some other categories of French citizens after French Constitutional Court rules health pass, mandatory vaccination of health workers constitutional amid nationwide protests

While critics of the legislation have accused the government of trampling on civil rights and even sliding towards a “dictatorship,” the authorities have insisted that the package is designed only to encourage vaccination.

Ace Related News:

France: Thousands demonstrate in Paris against health passes, mandatory COVID vaccinationJuly 24, 2021:

Protests Rage Across Europe as Lockdown, Vaccination Mandates Start | The Epoch Times

FIERCE CLASHES between protesters & police in Paris as tens of thousands rally against Covid certs, vax mandates in France (VIDEO) | RT World NewsJuly 25, 2021

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#france, #passports, #protests, #vaccine

(MOSCOW) #Coronavirus Report: Russia exported more than $300 million worth of vaccines in the first five months of the year, customs data shows — more than the entire value of vaccines sold in the previous three years combined #AceHealthDesk report

#AceHealthReport – Aug.05: The increase was driven by foreign sales of Russia’s flagship Sputnik V anti-coronavirus vaccine, with millions of doses shipped overseas to customers including Argentina, Kazakhstan, Belarus, Hungary and Serbia.

#CoronavirusNewsDesk says Russia Has Earned $300-Million on Vaccine Exports So Far, with Sputnik V to Argentina, Kazakhstan, Belarus, Hungary & Serbia …….

Vaccine Report:

Aug. 04, 2021Russian Sputnik-V vaccines arrived at Aurora International Airport in Guatemala CityJohan ORDONEZ / AFP

The figure also includes sales of non-coronavirus vaccines — mainly shots against yellow fever and flu. But the Trade Ministry told the RBC business site that the large jump in sales was mainly due to Sputnik V exports. 

Russia has not revealed specific details on how much money it has made, or expects to make, from selling Sputnik V around the world.

In the whole of 2019, Russia exported $60 million of vaccines — a figure which grew in 2020 to $70 million. 

In the first five months of 2021, Moscow’s vaccine exports surged to a total of $304 million, according to customs data analyzed by RBC. That compares to just $10 million during the same period of 2020.

But amid production delays and numerous delivery issues among key Sputnik V customers, Russia’s growth in vaccine exports significantly lags the increases in sales registered by other countries exporting coronavirus shots: https://datawrapper.dwcdn.net/1d4UU/1/

China increased its vaccine exports almost 100-fold during the first five months of 2021 — selling $1.8 billion worth compared to just $19 million in the same period last year. While the European Union has sold $6.4 billion in vaccines outside the bloc, up from $4.3 billion, and the U.S. also exported more than $1.5 billion.

Russia is hoping a successful Sputnik V export drive could help the country break into the lucrative medical exports market, providing both a new income stream for coronavirus vaccines, and also opening the door for Russia to sell other pharmaceutical products around the world.

(C)MOSCOW TIMES 2021

#AceNewsDesk report ………Published: Aug.05: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#russia, #argentina, #belarus, #china, #covid19, #hungary, #kazakhstan, #moscow, #serbia, #sputnik-v, #vaccine

(BEIJING) #Coronavirus Report: Latest outbreak two weeks ago in Nanjing is spreading #Delta variant rapidly and it testing their vaccine efficacy as massive testing underway #AceHealthDesk report

#AceHealthReport – Aug.02: The latest outbreak started two weeks ago in the eastern city of Nanjing, where nine airport cleaners were found to be infected during a routine test. Since then, the cluster has spread to at least 26 cities across China, including a tourist hot spot in the southern province of Hunan and the capital Beijing.

#CoronavirusNewsDesk says China’s hardline zero #COVID19 strategy is facing a fresh challenge from the rapid spread of the Delta variant, amid concerns over the efficacy of Chinese vaccines against the highly contagious strain …..with more than 300 cases have been detected within a span of 10 days.

BBC Asia: Delta Variant Beijing

The Delta variant, which appears to cause more severe illness and spreads as easily as chickenpox according to an internal document from the US Centers for Disease Control and Prevention (CDC), has wreaked havoc across the world. Now, it is causing China’s worst outbreak in months.China reported 328 local Covid-19 infections in July, close to the total from the previous five months, according to the National Health Commission. Although that’s only a fraction of the cases reported in countries like the United States and the United Kingdom, it is perceived as a serious threat in China, where authorities attempt to keep local infections at zero.

China Covid: Concerns grow as Delta outbreak spreads as a fresh #COVID19 outbreak in China has spread to more locations, raising concerns in local media over the country’s vulnerability to the highly contagious Delta variant.

A medical worker collects swab from a resident for nucleic acid testing at dawn
Authorities in China are testing millions of people after an outbreak spread to 18 provinces

Local headlines have been dominated by news on the outbreak, and the country’s top respiratory diseases specialist has reportedly expressed grave concern.

The government has imposed fresh travel restrictions and is testing millions.

It is unclear how many in China are fully vaccinated, although authorities say more than 1.6 billion doses have been administered so far.

A total of 15 provinces and municipalities have now confirmed cases, of which 12 are connected to an outbreak that began in Nanjing in China’s eastern Jiangsu province. Authorities have attributed the spread to the Delta variant and the domestic tourist season.

Although case numbers are considerably lower than other places, it is considered the largest outbreak in months in China, a country that was largely successful in controlling the virus within its borders last year.

Cases first emerged in July in Nanjing airport, among workers who had cleaned a plane that arrived from Russia.

Authorities promptly tested 9.2 million residents of Nanjing and imposed lockdown on hundreds of thousands of people.

But over the weekend the spotlight turned to popular tourist destination Zhangjiajie in central Hunan province, where many of the latest cases have emerged. Travellers from Nanjing were thought to have visited the city recently.

Health officials have zeroed in on a theatre in Zhangjiajie, and are now trying to track down about 5,000 people who attended performances and then travelled back to their home cities. 

One performance alone had hosted about 2,000 people, according to reports. 

All attractions in Zhangjiajie have been closed and tourists are being asked to take a Covid test before leaving the city, local media reported.

“Zhangjiajie has now become the new ground zero for China’s epidemic spread,” Zhong Nanshan, China’s leading respiratory disease expert, told reporters.

The new outbreak has reached Beijing too, with the city reporting several locally transmitted infections. 

All of Beijing’s air, bus and travel links to areas with positive cases have been cut. All tourists have also been banned from entering the capital, and officials are only allowing “essential travellers” with negative Covid tests to enter.

China is also battling a rise in cases in Zhengzhou in northern Henan province, which saw devastating floods just last month, as well as Hainan island.Drone pictures show the extent of damage as our correspondent reports on the situation on the ground

The Global Times newspaper has called the outbreak the “most serious since Wuhan”, and in a separate editorial criticised “glaring loopholes” in Covid prevention measures.

“It is absolutely worrying if a single flaw can affect many provinces and regions across the country… it shows that our systematic progress in fighting the epidemic needs to be strengthened,” it said.

The outbreak has raised concerns about vaccines, as it emerged that some of those infected had been vaccinated.

Shao Yiming, a researcher with China’s Centre for Disease Control and Prevention, told reporters on Saturday that breakthrough infections in vaccinated people “are expected”.

Sinovac and Sinopharm’s vaccines – two of the most commonly used jabs in China – have been shown to be 50% to 79% effective in preventing symptomatic Covid infection in clinical trials around the world, but are highly effective in preventing hospitalisations or deaths….

Chinese authorities responded swiftly with mass testing, targeted lockdowns, extensive contact tracing and quarantine of close contacts — a tried and tested formula that has helped it quickly tame local flare-ups since March 2020.In Nanjing, a city of 9.3 million people, residents went through threerounds of coronavirus testing in two weeks. Residential compounds with confirmed cases were locked down, while cinemas, gyms, bars and libraries were shuttered. In Zhangjiajie, where a theater performance attended by thousands of people has fueled concerns of a super-spreader event linked to the Nanjing cluster, all tourist destinations were shut down and residents are banned from leaving their compounds.

Restrictions have also been ramped up in Beijing, which reported its first local infection in nearly six months last week. Since then, five local cases with travel history to Zhangjiajie have been detected. The city has banned people from medium- or high-risk areas from entering, suspending flights, trains and buses from Covid-hit places.

Huang Yanzhong, senior fellow for Global Health at the Council on Foreign Relations, said Chinese authorities are responding to the threat of the Delta variant with the same playbook used in previous outbreaks, but in an even more stringent manner — several cities have been placed under effective lockdowns.

“It shows the problem of diminishing returns of the existing ‘zero-tolerance’ approach,” he said.

Elsewhere in the world, countries with relatively high vaccination rates are increasingly choosing to tolerate a degree of transmission, as long as it doesn’t translate into a surge in hospitalizations and deaths. In China, however, authorities appear intent on imposing strict restrictions despite having administered more than 1.65 billion homegrown vaccine doses — ranking above the US in terms of doses administered per 100 people.

The rapid spread of the Nanjing cluster to cities across the country has triggered concerns over the level of protection currently offered by Chinese vaccines against the Delta variant. On July 22, two days after the Nanjing cluster was first detected, a health expert in the city said the “vast majority” of those infected there had been vaccinated, except for one person under 18 years old. Airport staff, along with medical workers and border control personnel, were among the first to be vaccinated in China. 

Chinese authorities have not offered a fuller breakdown of how many subsequent cases were also vaccinated. 

Several other countries that used Chinese vaccines have also reported infections among vaccinated people. In June, Indonesian officials said more than 350 medical workers in the country had contracted Covid-19 despite being inoculated with vaccines produced by Chinese company Sinovac Biotech. Breakthrough cases have also been reported among people fully immunized with more effective vaccines, such as those produced by Pfizer/BioNTech and Moderna. In a report released Friday, the US CDC found that about 74% of the 469 Massachusetts residents who were infected in July had been fully vaccinated — with the Delta variant revealed as the main culprit.

Chinese experts have tried to assure the public that Chinese vaccines are still effective against the Delta variant.

On Saturday, Shao Yiming, an expert at the Chinese Center for Disease Control and Prevention, said at a news conference that breakthrough infections are a “normal” phenomenon, while stressing that such cases are only a minority among vaccinated people around the world. Feng Zijian, another Chinese health expert, added that while their immunity level against the Delta variant may be lower, existing vaccines still provide good enough prevention and protection.

But Huang, the expert at the Council on Foreign Relations, said the relatively low efficacy of Chinese vaccines against the Delta variant would only push authorities to double down on their “zero tolerance” containment-based approach as opposed to the mitigation-based method adopted elsewhere.

“That means China is likely still months away from opening its borders to the world,” Huang said.

It remains to be seen if repeated lockdowns and mass testing drives can sustain public support in the long run. Tolerance for such measures could begin to wane if, as expected, the government maintains its hardline approach until after the Beijing Winter Olympics in February next year. 

But some prominent Chinese public health experts have raised the prospect that like elsewhere in the world, China will eventually need to learn to coexist with the coronavirus.

Zhang Wenhong, an infectious disease expert at Shanghai’s Huashan Hospital, said it might not be possible for existing vaccines to eradicate infections, and transmissions might still happen even after everyone is fully vaccinated.”More and more people now believe that the epidemic will not end in a short period of time, and may not end in a long time,” he wrote on Weibo. Whatever path China takes in the future should ensure “its connection to the world, a return to normal life, while at the same time protecting citizens from the fear of the virus,” he added.

SCMP – BBC News — CNN: By Laura He and Paul R. La Monica.

#AceHealthDesk report ……Published: Aug.02: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#beijing, #china, #efficacy, #vaccine

(BEIJING, China.) #Coronavirus Report: Ninety countries were relying on their #COVID19 vaccine but now they are battling major outbreaks with cases rising #AceHealthDesk report

#AceHealthReport – June.26: More than 90 countries are using Covid shots from China: Experts say recent infections in those places should serve as a cautionary tale in the global effort to fight the disease.

#CoronavirusNewsDesk – More Than 90 Countries Relied on Chinese Vaccines. Now They’re Battling Major Outbreaks after medical and delivery problems according to New York Times

By New York Times: June. 24, 2021

A funeral in Kudus, Indonesia, in May. Many of the countries that are experiencing fresh coronavirus outbreaks despite high inoculation rates relied on Chinese-made vaccines.

Mongolia promised its people a “Covid-free summer.” Bahrain said there would be a “return to normal life.” The tiny island nation of the Seychellesaimed to jump-start its economy.

All three put their faith, at least in part, in easily accessible Chinese-made vaccines, which would allow them to roll out ambitious inoculation programs when much of the world was going without.

But instead of freedom from the coronavirus, all three countries are now battling a surge in infections.

China kicked off its vaccine diplomacy campaign last year by pledging to provide a shot that would be safe and effective at preventing severe cases of Covid-19. Less certain at the time was how successful it and other vaccines would be at curbing transmission.

Now, examples from several countries suggest that the Chinese vaccines may not be very effective at preventing the spread of the virus, particularly the new variants. The experiences of those countries lay bare a harsh reality facing a postpandemic world: The degree of recovery may depend on which vaccines governments give to their people.

In the Seychelles, Chile, Bahrain and Mongolia, 50 to 68 percent of the populations have been fully inoculated, outpacing the United States, according to Our World in Data, a data tracking project. All four ranked among the top 10 countries with the worst Covid outbreaks as recently as last week, according to data from The New York Times. And all four are mostly using shots made by two Chinese vaccine makers, Sinopharm and Sinovac Biotech.

“If the vaccines are sufficiently good, we should not see this pattern,” said Jin Dongyan, a virologist at the University of Hong Kong. “The Chinese have a responsibility to remedy this.”

 A vaccination on Chiloé Island, Chile. In Chile, the Seychelles, Bahrain and Mongolia, 50 to 68 percent of the populations have been fully vaccinated.

A vaccination on Chiloé Island, Chile. In Chile, the Seychelles, Bahrain and Mongolia, 50 to 68 percent of the populations have been fully vaccinated.Credit…Alvaro Vidal/Agence France-Presse — Getty Images

Scientists don’t know for certain why some countries with relatively high inoculation rates are suffering new outbreaks. Variants, social controls that are eased too quickly and careless behavior after only the first of a two-shot regimen are possibilities. But the breakthrough infections could have lasting consequences.

In the United States, about 45 percent of the population is fully vaccinated, mostly with doses made by Pfizer-BioNTech and Moderna. Cases have dropped 94 percent over six months.

Israel provided shots from Pfizer and has the second-highest vaccination rate in the world, after the Seychelles. The number of new daily confirmed Covid-19 cases per million in Israel is now around 4.95.

In the Seychelles, which relied mostly on Sinopharm, that number is more than 716 cases per million.

Disparities such as these could create a world in which three types of countries emerge from the pandemic — the wealthy nations that used their resources to secure Pfizer-BioNTech and Moderna shots, the poorer countries that are far away from immunizing a majority of citizens, and then those that are fully inoculated but only partly protected.

China, as well as the more than 90 nations that have received the Chinese shots, may end up in the third group, contending with rolling lockdowns, testing and limits on day-to-day life for months or years to come. Economies could remain held back. And as more citizens question the efficacy of Chinese doses, persuading unvaccinated people to line up for shots may also become more difficult.

One month after receiving his second dose of Sinopharm, Otgonjargal Baatar fell ill and tested positive for Covid-19. Mr. Otgonjargal, a 31-year-old miner, spent nine days in a hospital in Ulaanbaatar, the capital of Mongolia. He said he was now questioning the usefulness of the shot.

“People were convinced that if we were vaccinated, the summer will be free of Covid,” he said. “Now it turns out that it’s not true.”

Xi Jinping, China’s leader, pledged to deliver a Chinese vaccine that could be easily stored and transported to millions of people around the world. He called it a “global public good.”

Xi Jinping, China’s leader, pledged to deliver a Chinese vaccine that could be easily stored and transported to millions of people around the world: He called it a “global public good.”Credit…Andrea Verdelli/Getty Images

Beijing saw its vaccine diplomacy as an opportunity to emerge from the pandemic as a more influential global power. China’s top leader, Xi Jinping, pledged to deliver a Chinese shot that could be easily stored and transported to millions of people around the world. He called it a “global public good.”

Mongolia was a beneficiary, jumping at the chance to score millions of Sinopharm shots. The small country quickly rolled out an inoculation program and eased restrictions. It has now vaccinated 52 percent of its population. But on Sunday, it recorded 2,400 new infections, a quadrupling from a month before.

In a statement, China’s Foreign Ministry said it did not see a link between the recent outbreaks and its vaccines. It cited the World Health Organization as saying that vaccination rates in certain countries had not reached sufficient levels to prevent outbreaks, and that countries needed to continue to maintain controls.

“Relevant reports and data also show that many countries that use Chinese-made vaccines have expressed that they are safe and reliable, and have played a good role in their epidemic prevention efforts,” the ministry said. China has also emphasized that its vaccines target severe disease rather than transmission.

No vaccine fully prevents transmission, and people can still fall ill after being inoculated, but the relatively low efficacy rates of Chinese shots have been identified as a possible cause of the recent outbreaks.

The Pfizer-BioNTech and Moderna vaccines have efficacy rates of more than 90 percent. A variety of other vaccines — including AstraZenecaand Johnson & Johnson — have efficacy rates of around 70 percent. The Sinopharm vaccine developed with the Beijing Institute of Biological Products has an efficacy rate of 78.1 percent; the Sinovac vaccine has an efficacy rate of 51 percent.

The Chinese companies have not released much clinical data to show how their vaccines work at preventing transmission. On Monday, Shao Yiming, an epidemiologist with the Chinese Center for Disease Control and Prevention, said China needed to fully vaccinate 80 to 85 percent of its population to achieve herd immunity, revising a previous official estimate of 70 percent.

Data on breakthrough infections has not been made available, either, though a Sinovac study out of Chile showed that the vaccine was less effective than those from Pfizer-BioNTech and Moderna at preventing infection among vaccinated individuals.

A representative from Sinopharm hung up the phone when reached for comment. Sinovac did not respond to a request for comment.

William Schaffner, medical director of the National Foundation for Infectious Diseases at Vanderbilt University, said the efficacy rates of Chinese shots could be low enough “to sustain some transmission, as well as create illness of a substantial amount in the highly vaccinated population, even though it keeps people largely out of the hospital.”

Mongolia now ranks among the top countries that have fully vaccinated its population, inoculating about 52 percent of its people. But on Sunday, it recorded 2,400 new infections, quadrupling from a month before.

Mongolia now ranks among the top countries that have fully vaccinated its population, inoculating about 52 percent of its people. But on Sunday, it recorded 2,400 new infections, quadrupling from a month before.Credit…Khasar Sandag for The New York Times

Despite the spike in cases, officials in both the Seychelles and Mongolia have defended Sinopharm, saying it is effective in preventing severe cases of the disease.

Batbayar Ochirbat, head researcher of the Scientific Advisory Group for Emergencies at Mongolia’s Ministry of Health, said Mongolia had made the right decision to go with the Chinese-made shot, in part because it had helped keep the mortality rate low in the country. Data from Mongolia showed that the Sinopharm vaccine was actually more protective than the doses developed by AstraZeneca and Sputnik, a Russian vaccine, according to the Health Ministry.

The reason for the surge in Mongolia, Mr. Batbayar said, is that the country reopened too quickly, and many people believed they were protected after only one dose.

“I think you could say Mongolians celebrated too early,” he said. “My advice is the celebrations should start after the full vaccinations, so this is the lesson learned. There was too much confidence.”

Some health officials and scientists are less confident.

Nikolai Petrovsky, a professor at the College of Medicine and Public Health at Flinders University in Australia, said that with all of the evidence, it would be reasonable to assume the Sinopharm vaccine had minimal effect on curbing transmission. A major risk with the Chinese inoculation is that vaccinated people may have few or no symptoms and still spread the virus to others, he said.

“I think that this complexity has been lost on most decision makers around the world.”

In Indonesia, where a new variant is spreading, more than 350 doctors and health care workers recently came down with Covid-19 despite being fully vaccinated with Sinovac, according to the risk mitigation team of the Indonesian Medical Association. Across the country, 61 doctors died between February and June 7. Ten of them had taken the Chinese-made vaccine, the association said.

The numbers were enough to make Kenneth Mak, Singapore’s director of medical services, question the use of Sinovac. “It’s not a problem associated with Pfizer,” Mr. Mak said at a news conference on Friday. “This is actually a problem associated with the Sinovac vaccine.”

Bahrain and the United Arab Emirates were the first two countries to approve the Sinopharm shot, even before late-stage clinical trial data was released. Since then, there have been extensive reports of vaccinated people falling ill in both countries. In a statement, the Bahraini government’s media office said the kingdom’s vaccine rollout had been “efficient and successful to date.”

Still, last month officials from Bahrain and the United Arab Emirates announced that they would offer a third booster shot. The choices: Pfizer or more Sinopharm.

Reporting was contributed by Khaliun Bayartsogt, Andrea Kannapell, Ben Hubbard, Asmaa al-Omar and Muktita Suhartono. Elsie Chen and Claire Fu contributed research.

#AceHealthDesk report …….Published: Jun.26: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#beijing, #china, #coronavirus, #covid19, #vaccine

(LONDON) JUST IN: #Coronavirus Report: The British government has been accused of aiming to covertly implement a national ID programme, after it partnered with a company that has advocated turning vaccine passports into a multi-purpose document #AceHealthDesk report

#AceHealthReport – June.22: Entrust, an IT firm that bills itself as a “global leader in identities, payments, and data protection,” was awarded a contract by the Department of Health and Social Care last month to work on the UK’s Covid-19 vaccine certificate system.

#CoronavirusNewsDesk – ‘UK govt gave contract to IT firm that is ‘openly plotting’ to turn vaccine passports into a national ID card, privacy group warns but opening up society after #COVID19 will come at a cost’

21 Jun, 2021 10:35  / Updated 2 hours ago

UK govt gave contract to IT firm that is ‘openly plotting’ to turn vaccine passports into a national ID card, privacy group warns

The company was given £250,000 ($346,000) to provide cloud-computing services for the government’s Covid-status certification scheme, iNews reported. The contract is due to expire in March 2022, but the government has the option of extending it for an additional year.

Health Secretary Matt Hancock stated last month that proof of vaccination will be “necessary” for international travel, and in recent weeks reports have emerged claiming that the UK government may require the document of people attending sporting events or other large gatherings. 

Judging from Entrust’s own stance on the issue, it’s possible that the government may have even more ambitious plans for the digital certificate. In a February blog post published on the company’s website, Jann Markey, Entrust’s product marketing director, argued that the advent of the vaccine passports could be used as an opportunity to roll out a national ID as part of “the infrastructure of the new normal.” Vaccine passports, voter ID and anti-protest laws are marching the UK into authoritarianism, but why should I bother resisting?

“Consider a national ID strategy: With the infrastructure and investment necessary to ensure a viable vaccine passport, why not redeploy this effort into a national citizen ID programme that can be used for multiple purposes including the secure delivery of government services, secure cross-border travel, and documentation of vaccination,” the blog, which explores vaccine passports in the “post-pandemic world,” states. 

Notably, the US-based company has already helped Albania, Ghana and Malaysia deploy national ID systems, iNews said. 

Entrust’s partnership with the UK government has already raised alarm among civil liberties organisations and lawmakers. 

Tory MP David Davis, a member of the anti-lockdown Covid Recovery Group, demanded an explanation from the government. He told iNews that it was “extraordinary” that the health department could ink deals with such companies without first getting permission from Parliament, adding that it was particularly worrying that a contract could be given to a firm “with this sinister attitude to surveillance of citizens.”

Former Conservative leader Sir Iain Duncan Smith echoed similar displeasure, claiming that the contract contradicts the “stated position of the government” and should be nixed. Biopolitical surveillance regimes’: Vaccine passports reveal the growing authoritarian tendencies of Western governments

Big Brother Watch, a privacy and civil liberties group, said the Entrust contract represents an attempt by the government to issue ID cards “by the backdoor.”  

“The fact that the government has done a deal with Entrust, a company which is openly plotting a route from vaccine passports to digital identity cards, only underlines what a serious threat Covid passes would be to our civil liberties and our privacy,” the organisation’s head of research, Jake Hurfurt, warned. 

A health department spokesperson insisted that the NHS app used to certify vaccination status will not be used as a national ID system, describing the scheme as a “simple and secure means” to allow for international travel. Entrust declined to comment when contacted by iNews.

#AceHealthDesk report ………Published: Jun.22: 2021:

Editor says …Sterling Publishing & Media Service Agency is not responsible for the content of external site or from any reports, posts or links, and can also be found here on Telegram: https://t.me/acenewsdaily all of our posts fromTwitter can be found here: https://acetwitternews.wordpress.com/ and all wordpress and live posts and links here: https://acenewsroom.wordpress.com/and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#it, #london, #passport, #u-k, #vaccine

(HONG KONG) HKU REPORT: The University announced on Friday that its research team had found a mutant strain of #COVID19 at the early phase of the pandemic with the characteristics of an attenuated vaccine, bringing a major breakthrough in the further development of related vaccines #AceHealthDesk report

#AceNewsReport – May.16: According to the researchers, findings of the study also suggested that the SARS-CoV-2 coronavirus is a cross-species event of infection from animals

#CoronavirusNewsDesk – HKU finds mutant strain that may shed light on virus vaccine: ‘In the study with hamsters, researchers from the State Key Laboratory of Emerging Infectious Diseases of the university found that the mutant strain of SARS-CoV-2 with no basic amino acid motif is almost non-pathogenic to hamsters’ These findings have recently been published in the science journal Nature Communications.

HKU REPORT:

This handout illustration image obtained Feb 27, 2020 courtesy of the National Institutes of Health shows a transmission electron microscopic image that shows SARS-CoV-2. (HANDOUT / NATIONAL INSTITUTES OF HEALTH / AFP)

HK-led study finds hepatitis C drug as potent COVID-19 treatment

Hamsters that have been infected with the mutant virus can completely resist the re-infection of the wild-type virus, suggesting that this non-pathogenic mutant strain of the SARS-CoV-2 has the characteristics of an attenuated vaccine, the study revealed.

The research also found that in human cell culture, the virus with the mutant strain has a reproductive rate even higher than that of the prototype virus, which is of great significance for the preparation of inactivated vaccines from the new coronavirus.

HKU shares quick COVID-19 testing technology with the world

According to the researchers, findings of the study also suggested that the SARS-CoV-2 coronavirus is a cross-species event of infection from animals.

Chen Honglin, a professor from the university’s department of microbiology and also a member of the research team, said the study indicated that the SARS-CoV-2 coronavirus is still in the process of adapting to humans, and more mutant strains will occur in the COVID-19 pandemic.

“At the same time, the mutant virus that loses the basic amino acid of the spike protein has low pathogenicity and higher reproductive ability in cultured cells than the original wild-type virus, and is an ideal strain for use in the production of inactivated vaccine,” Chen said.

#AceHealthDesk report ……Published: May.16: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#covid19, #hku, #hong-kong, #vaccine

(LONDON) Press Release Statement Report: The government’s statement following updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) that the Oxford/AstraZeneca vaccine is safe #AceHealthDesk report

#AceHealthReport – May.07: The Oxford/AstraZeneca vaccine is safe, effective and has already saved thousands of lives in the UK and around the world.

#CoronavirusNewsDesk Statement on AstraZeneca #COVID19 vaccine following JCVI update: The government’s statement following updated advice from the Joint Committee on Vaccination and Immunisation (JCVI)’

A government spokesperson said:

As the MHRA – the UK’s independent regulator – and the Joint Committee on Vaccination and Immunisation have said, the benefits of the vaccine far outweigh the risks for the vast majority of adults.

The government will follow today’s updated advice, which sets out that, as a precaution, it is preferable for people under the age of 40 with no underlying health conditions to be offered an alternative vaccine where possible once they are eligible, and only if doing so does not cause a substantial delay in accessing a vaccination.

More than 50 million vaccines overall have already been administered, and our current vaccine supply and rate of infection means we are able to take this precautionary step while remaining on track to achieve our target of offering a vaccine to all adults by the end of July.

Everybody who has already had a first dose of the Oxford/AstraZeneca vaccine should receive a second dose of the same jab, irrespective of age, except for the very small number of people who experienced blood clots with low platelet counts following their first vaccination.

When people are called forward, they should get their jab. Vaccines are the best way out of this pandemic and provide strong protection against COVID-19.

Background information

Public Health England (PHE) analysis indicates that the COVID-19 vaccination programme prevented more than 10,000 deaths in England up to the end of March.

All safety reports are rigorously investigated and anyone with unexpected symptoms should speak with a healthcare professional.

All medicines have a risk of side effects, even common medicines like paracetamol.

#AceHealthDesk report ……Published: May.07: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#health, #london, #vaccine

(LONDON) GOVUK Press Statement Report: A new study led by Sheffield & Oxford Universities with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against #COVID19 after just one dose of the Pfizer vaccine #AceHealthDesk report

#CoronavirusNewsDesk – New study finds strong immune response following #COVID19 vaccination: ‘Study led by Sheffield and Oxford Universities finds that 99% of people have robust immune response against COVID-19 after one dose of Pfizer vaccine’

  • 237 healthcare workers tested for antibody and T cell responses, as part of the largest and most in-depth study on the immune response following COVID-19 vaccination
  • First findings from DHSC-funded PITCH study shows one dose of the Pfizer vaccine generates robust T cell and antibody responses in 99% of people
  • Study shows people who have previously had COVID-19 generate stronger T cell and antibody responses following one dose of the Pfizer vaccine

A new study led by Sheffield and Oxford Universities with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.

The Protective Immunity from T cells to COVID-19 in health workers study (PITCH) examined how the immune system responds to COVID-19 after one dose of the Pfizer vaccine among people who have been infected by COVID-19 before and those who have not.

It suggests one dose of the vaccine protects against severe disease, supporting the decision to delay the second dose and provide protection to as many higher-risk groups as possible by providing more first doses. The study showed after 2 doses levels of protection were even stronger, underlining the importance of people coming forward for their second dose.

Between 9 December 2020 and 9 February 2021, researchers from the Universities of Sheffield, Oxford, Liverpool, Newcastle and Birmingham analysed blood samples from 237 healthcare workers to understand their T cell and antibody responses following vaccination from the Pfizer vaccine.

The study also sheds light on the impact of previous infection from COVID-19 on people’s immune response to vaccination. It found people who had previously been infected with COVID-19 showed higher T cell and antibody responses after one dose of the Pfizer vaccine compared with people who had never had COVID-19 before and had one dose of the vaccine.

The researchers discovered that among people who had had COVID-19 in the past, the T cell response expanded after vaccination to recognise more regions of the COVID-19 spike protein – which attacks the immune system and causes severe disease. This means, even in those already infected, vaccination from the Pfizer jab provides better protection and an enhanced immune response to COVID-19 than the immune response from natural infection.

It is not yet known how long T cell and antibody response lasts following infection. The first dose of both the Pfizer and AstraZeneca vaccine offer good levels of protection, but to get maximum protection it is vital everyone gets a second dose when invited as 2 doses of the vaccine will provide longer-lasting protection from the virus.

Health and Social Care Secretary Matt Hancock said:

The PITCH study presents further proof that vaccines provide excellent protection against the virus. Thanks to the incredible efforts of our vaccination programme, over half of all adults in the UK have had the jab, and we remain on track to offer all adults a vaccine by the end of July.

A second vaccine jab is crucial for longer-term protection, regardless of whether you have previously had COVID-19 or not, and I urge everyone to make sure they attend their second appointment – to keep themselves and those around them safe.

Health Minister Lord Bethell said:

These findings from the PITCH study are crucial to increasing our understanding of the immune response to COVID-19 and how the Pfizer vaccine is working to protect people across the UK already.

I urge everyone to come forward to be vaccinated when invited and to take up both doses of the vaccine as both are vital to ensuring long-term protection from COVID-19.

Key findings from the PITCH study

  • Among individuals who had not had COVID-19 in the past and had received 2 doses of the Pfizer vaccine, T cell response was as strong as people who had had previous COVID-19 infection and one vaccine dose.
  • After one dose of the Pfizer vaccine, individuals who had previous COVID-19 infection showed higher antibody and T cell responses compared with people who had not been infected before. Antibody responses were 6.8 times higher and T cell responses 5.9 times higher.
  • Among individuals who had not had COVID-19 in the past and had received one dose of the Pfizer vaccine, antibody and T cell responses were at a similar or higher level compared to those who had previously been infected but not been vaccinated.
  • There was a 10-fold greater spike-specific T cell responses following vaccination in people with previous infection compared to those who had no prior infection.
  • There was no link between age and levels of T cell/antibody response.

An effective vaccine is one that that saves lives and reduces hospitalisations. Both the Pfizer and Oxford-AstraZeneca vaccines have been shown to be highly effective in reducing COVID-19 infections among older people aged 70 years, according to previously published research carried out by Public Health England. In the over 80s, data suggest that a single dose of either vaccine is more than 80% effective at preventing hospitalisation, around 3 to 4 weeks after the jab.

Further research will continue to deepen our understanding of the immune responses over the longer term and what it means for protection against COVID-19 in the real world.

Even after vaccination everyone must continue to follow the rules – remembering Hands, Face, Space – as it may still be possible to pass the virus on to others after having the jab.

Dr Thushan de Silva, study author from the University of Sheffield, said:

Our study is one of the largest and most comprehensive accounts of the immune response to one dose of Pfizer/BioNTech vaccine comparing previously infected and infection-naive individuals. Our results demonstrate that T cell and antibody responses induced by natural infection are boosted significantly by a single dose of vaccine. While the response to a single dose was lower in infection-naïve individuals, it was still equivalent or better than the immunity in previously infected individuals before it is boosted by vaccination.

Professor Susanna Dunachie, PITCH study lead from the University of Oxford, said:

Our study highlights the importance of studying both aspects of immune protection when trying to understand the underlying mechanisms of the immune response to COVID-19 vaccination. Interestingly, we also found that vaccination improves the breadth of T cell responses generated in previously infected individuals. In immunology, this is a good thing as it means that you are more likely to maintain protection against new mutations of the virus, and further work will assess how long these vaccine responses last. It’s still important that everyone follows NHS guidelines to get 2 doses of the vaccine, even if you think you may have previously had COVID-19.

The PITCH study has been a great opportunity to work collaboratively across 5 university hospitals and with Public Health England to look at T cell responses to SARS-CoV-2 at greater scale and depth than a single research centre can. By building on the national SIREN Study and putting our heads together, we are contributing towards illuminating the role of T cells in protection against COVID-19 from vaccines and previous infection.

Professor Paul Klenerman, PITCH study lead from the University of Oxford, said:

T cells are an important component of immunity to viruses – but typically much harder to measure than antibodies. To set this up at scale across the UK in the midst of a pandemic was a big challenge but the very clear data found by PITCH show just how informative this approach can be.

Background information

See the pre-print report on T cell and antibody responses available on the Lancet website

This study formed part of the PITCH Study (Protective Immunity from T-cells in Healthcare workers), which was funded by the UKs Department of Health and Social Care. A contribution was also made from the UK Coronavirus Immunology Consortium (funded by UK Research and Innovation and the National Institute for Health Research).

Of the 237 healthcare workers, 113 had previously been infected with COVID-19 compared to 124 healthcare workers who had not. For those who had not previously had COVID-19, 103 were given one dose of the vaccine and 21 were given 2 doses, with a gap of 23 days between doses. The researchers took blood samples from participants prior to and 28 days after vaccination to measure various aspects of the immune response, including antibodies and T cells.

A range of analyses were used to examine aspects of the T cell response including the magnitude of response and the response to different proteins from SARS-CoV-2. Carrying out these T cell analyses is much more complex than antibody studies and difficult to undertake at scale – but this study is the largest and most in depth in the world to date in this field.

References

  • Polack et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine 2020; 383(27): 2603-15.
  • Hall et al. Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020. medRxiv 2021: 2021.01.13.21249642.

#AceHealthDesk report ……Published: Mar.29: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#govuk, #london, #vaccine

(BRUSSELS) #Coronavirus Report: EU Lawmakers pushing to waive intellectual property rights for #COVID19 to increase ‘Global Vaccine Access’ for their members #AceHealthDesk report

#AceHealthReport – Mar.25: Pressure is growing on the European Commission and EU member states to reconsider their staunch opposition to measures that could open the possibility of a massive increase in #Covid19 vaccine production worldwide.

#CoronavirusNewsDesk – The EU Should Stop Blocking Efforts to Increase Global Vaccine Access: European Lawmakers Join Push for Waiving Intellectual Property Rules for #Covid19 Response: https://t.me/reuters_news_agency/69546
Reuters Wire News, [Mar 24, 2021 at 6:18 PM] UK and EU say looking to create ‘win-win’ situation on COVID-19 vaccines

LONDON (Reuters) – Britain and the European Commission said they are discussing how they can work together to create a “win-win” situation on COVID-19 vaccines after the bloc threatened to take tougher measures to curb the export of deliveries of shots: The European Commission has threatened to ban exports to countries like Britain that have higher vaccination rates but do not export shots to the EU. The aim is to safeguard supplies for the bloc’s own citizens as they face a third wave of the pandemic.: Given our interdependencies, we are working on specific steps we can take – in the short-, medium- and long term – to create a win-win situation and expand vaccine supply for all our citizens,” they said in a joint statement: In the end, openness and global cooperation of all countries will be key to finally overcome this pandemic and ensure better preparation for meeting future challenges. We will continue our discussions.”

HRW Report: In October 2020: In an unprecedented joint appeal, hundreds of lawmakers across Europe have joined the Director-General of the World Health Organization, over 100 national governments, trade unions, and hundreds of civil society organizations, including Human Rights Watch, in urging the EU and its member states to support a proposal by India and South Africa to temporarily suspend certain intellectual property rules until widespread vaccination is in place globally.

A person in Soweto, South Africa receives an injection as they participate in a clinical trial for a Covid-19 vaccine in June 2020. 
A person in Soweto, South Africa receives an injection as they participate in a clinical trial for a Covid-19 vaccine in June 2020.  © 2020 Siphiwe Sibeko/AFP via Getty Images

The proposal would facilitate technology transfers so that Covid-19 medical products, including vaccines, could be produced quickly and affordably by manufacturers around the world, in line with a rights-based approach to the pandemic and growing calls for a “peoples’ vaccine” freely available to all.

In the absence of such open sharing of know-how, the vast majority of vaccines currently available are going to some of the world’s richest countries, exacerbating global inequalities and leaving many low- and middle-income countries at the bottom of the waiting list. Human Rights Watch and many others have been warning against this situation for months.

As EU heads of state prepare to discuss the bloc’s response to the pandemic later this week, they should heed the calls coming from elected representatives and citizens and reconsider their opposition to the intellectual property waiver. As European lawmakers put it, “we will not defeat the virus until we defeat it everywhere.” And with new strains emerging all the time, we will hardly defeat it anywhere without a mass global vaccine rollout. The pandemic has already had an enormous human and economic cost. European leaders should stop standing in the way of a measure that could accelerate and increase global vaccine production and availability and bring us closer to ending the pandemic.

#AceHealthDesk report ……..Published: Mar.25: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#brussels, #coronavirus, #vaccine

(BRUSSELS) Astra Zeneca Report: EU Commission Head Ursula Von Der Leyden says until the pharmacy company meets it supply obligations to Europe she threatens to forbid exports #AceHealthDesk report

#AceHealthReport – Mar.21: The European Union could stop AstraZeneca from exporting its COVID-19 vaccine from the bloc if the British-Swedish pharma company does not meet its supply obligations, European Commission President Ursula von der Leyen said in comments published on Saturday.

‘EU warns AstraZeneca of export ban if bloc not supplied first: European Commission head Ursula von der Leyen has upped the pressure on pharma company AstraZeneca, threatening to forbid planned exports until the firm fulfils its obligations to Europe in comments on Saturday’

Vial of AstraZeneca vaccoine with a syringe needle before it

“We have the possibility to forbid planned exports. That is the message to AstraZeneca: You fulfill your contract with Europe before you start delivering to other countries,” von der Leyen told newspapers from the Funke Media Group.

She said the company had delivered only 30% of the doses promised in the first quarter of 2021. She also pointed out that although the contract with AstraZeneca had stipulated that the EU would receive vaccines from factories in the EU and Britain, “we have received nothing from the Britons, while we deliver vaccines to them.”

Ursula von der Leyen giving the thumbs-up sign

Despite the confidence exuded by von der Leyen here, the EU is having grave problems with its vaccination drive.

Von der Leyen referred to statistics showing that at least 41 million doses of coronavirus vaccine had been exported from the EU to 33 countries, despite a shortfall in vaccine supplies in the bloc itself. According to the commission, 9 million doses have gone from the EU to the UK and a million to the US. 

“I cannot justify to European citizens why we export millions of vaccine doses to countries that produce vaccines themselves — and from whom nothing comes back,” von der Leyen said. “And I can barely justify exports to countries that have a much higher vaccination rate and far fewer infections than the EU.”

She called on other countries to reciprocate the EU’s openness and said the bloc was inviting national leaders for discussion.

Vaccination programs in the EU, including Germany, have been comparatively slow  in getting underway, partly because of a lack of doses.

tj/aw (dpa, AFP)

#AceHealthDesk report ………..Published: Mar.21: 2021:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com

#astra-zeneca, #brussels, #covid19, #eu, #europe, #vaccine

FLORIDA: ‘ FLU VACCINE PARALYSES 10-YEAR OLD HEALTHY CHILD ‘

AceNewsServices – FLORIDA – Nov.11 – Sure, vaccines are safe — except when they randomly trigger extreme brain inflammation that leads to vision loss, paralysis and an inability to speak.

This is what happened to now-10-year-old Marysue Grivna of Tampa, Florida, just four days after she received a flu vaccine, which left her completely debilitated with a serious brain disease known as acute disseminated encephalomyelitis, or ADEM.  

It all began on November 22, 2013, when young Marysue was taken in to get a seasonal flu vaccine. Just days later, the child began to get sick and quickly developed symptoms of paralysis.

Worried, her parents took her in for an evaluation and it was determined that she had succumbed to an immune disorder caused by inflammation of the brain. 

Similar to multiple sclerosis, ADEM manifests as an autoimmune disorder in which the body attacks itself, in this case targeting the protective coverings surrounding nerve fibres. Known as myelin, these coverings are meant to protect nerves in the brain and spinal cord, for instance, from being harmed. In their absence, symptoms like loss of vision and paralysis can occur.

“Her father Steven and I are certain, due to all our research, that this was what caused Marysue’s condition,” stated the girl’s mother, Carla, during a recent interview with Fox & Friends. “The doctors won’t confirm it or deny it… [but] she was a happy, healthy, running, and playing nine-year-old.

Then this happened read more here …….. Source: 

#ANS2014 

#acenewsservices, #adem, #brain, #flu, #vaccine

PUTIN: ‘ Regrettably, the Vaccine Against the Nazi Virus Developed at the Nuremberg Trials is Losing its Efficiency in Some European State ‘

#AceNewsServices – MOSCOW – October 14. /TASS/. Russia President Vladimir Putin is worried over growing neo-Nazi tendencies in the Baltic states and in Ukraine.

“Regrettably, the vaccine against the Nazi virus developed at the Nuremberg trials is losing its efficiency in some European state,” Putin said in an interview with Serbia’s daily newspaper Politika on Tuesday.

“A vivid example of this is open manifestations of neo-Nazism, which have become routine in Latvia and other Baltic countries.” RIA Novosti. 

“In this sense, the situation in Ukraine causes special worries.

The February anti-constitutional coupe in that country was driven by nationalists and other radical groups,” he said.

#ANS2014

#moscow, #nazi, #nuremberg-trials, #vaccine

` MERS Coronavirus Claims its First Victim in `Yemen ‘ whilst Saudi Arabia says a Foreigner has Died ‘

#AceHealthNews – SAUDI ARABIA – April 13 – (ALJ) – A foreigner has died from the deadly MERS coronavirus in Saudi Arabia, while Yemen has reported its first case of the disease.

The foreign man, whose nationality has not been disclosed, died from the coronavirus as eight others in the kingdom, including five health workers in the city of Jeddah, were infected.

The death brings the nationwide toll in the world’s most-affected country to 68, with 189 people infected.

The Saudi health ministry, which announced the death, said five health workers – two women and three men – and three other people had been infected by MERS in Jeddah.

The announcement came days after panic over the spread of the virus among medical staff led to the closure of the emergency room at the city’s main public hospital.

Deadly virus

The World Health Organisation (WHO) on Friday said that it had been told of 212 laboratory-confirmed cases of MERS infection worldwide, of which 88 were fatal.

MERS is considered a deadlier but less-transmissible cousin of the SARS virus that erupted in Asia in 2003 and infected 8,273 people, nine percent of whom died.

Experts are still struggling to understand MERS, for which there is no known vaccine.

A study has said the virus has been “extraordinarily common” in camels for at least 20 years, and may have been passed directly from the animals to humans.

The UAE news agency WAM said on Friday an expatriate health worker had died from the virus and five others had been infected in the Gulf state. This followed Saudi reports last week of two deaths and nine other cases of infection in the kingdom, including among hospital staff.

#ANS2014

#coronavirus, #mers, #sars, #saudi-arabia, #united-arab-emirates-uae, #vaccine, #world-health-organisation-who, #world-health-organization

#AceHealthNews: “Protecting Your Family Against Flu Can Have Side-Affects”

#AceHealthNews says Scientist exposes flu shots lies and doom-and-gloom media propaganda

Sunday, January 19, 2014
by Mike Adams, the Health Ranger
Editor of NaturalNews.com (See all articles…)
Tags: scientistflu shot liesmedia propaganda

The mainstream media has utterly abandoned science in the push for more flu shot propaganda, entirely failing to mention any of the risks associated with vaccines. According to nearly every story published in the mainstream media, flu shot vaccines offer almost certain protection against the flu while carrying absolute zero risk (risk is never mentioned).

Such a position is utterly anti-scientific. All medical interventions carry inherent risk, and this is especially so when vaccines admittedly contain mercury, MSG, formaldehyde and aluminum, all potent neurotoxic chemicals or heavy metals.

This is why vaccines routinely cause seizures in children, fevers, vomiting, comas and even death. The risk of this becoming known to the public is so great that a private, unconstitutional court called the “vaccine court” was established in order to pay off parents of vaccine-damaged children while requiring them to sign non-disclosure agreements to force them into silence. (Click here to see the astonishing video revealing this.)

Media stories that don’t mention flu shot risks are irresponsible and may cause harm to the public

Any media source that publishes an article pushing flu shots without offering a reasonable discussion of the inherent risk from doing so is acting in a highly irresponsible manner, potentially putting millions of children in harm’s way. Yet mainstream media journalists routinely fail to discuss any risks whatsoever of vaccines, almost as if such risks did not exist.

These journalists are either scientifically illiterate and not aware of such risks, or they are actively deciding to censor such discussions from their stories, thereby conspiring with the vaccine industry to keep the public ignorant of a medical intervention which may cause them serious harm or death. Such actions are highly unethical and smack of a complete lack of journalistic professionalism.

Watch the new Health Ranger video explanation

To learn more about flu shot propaganda, media lies and the abandonment of real science by the vaccine industry, watch this new screen cast video I just posted:

 

Enhanced by Zemanta

#acehealthcarenews, #acehealthnews, #influenza, #influenza-vaccine, #inherent-risk-accounting, #journalism-ethics-and-standards, #mainstream-media, #non-disclosure-agreement, #risk, #vaccine